{"id":53,"date":"2025-07-06T18:47:38","date_gmt":"2025-07-06T15:47:38","guid":{"rendered":"http:\/\/profdraliuzunkoy.com\/?p=53"},"modified":"2025-07-06T18:49:17","modified_gmt":"2025-07-06T15:49:17","slug":"kalin-bagirsak-kanseri","status":"publish","type":"post","link":"http:\/\/profdraliuzunkoy.com\/?p=53","title":{"rendered":"Kal\u0131n Ba\u011f\u0131rsak Kanseri"},"content":{"rendered":"\n


Kal\u0131n ba\u011f\u0131rsaklar sindirim sistemimizin son k\u0131sm\u0131n\u0131 olu\u015fturur. Yakla\u015f\u0131k 150-200 cm boyunda olup, son 15 cm.lik k\u0131sm\u0131na rektum ad\u0131 verilir. Bu b\u00f6lgede g\u00f6zlenen kanserler v\u00fccudumuzda \u00fc\u00e7\u00fcnc\u00fc s\u0131kl\u0131kla (t\u00fcm kanserlerin %10-15’i) g\u00f6zlenmeleri ve ikinci s\u0131kl\u0131kta \u00f6l\u00fcme sebep olmalar\u0131ndan dolay\u0131 \u00f6nemlidir. Bulgu ve belirtilerinin bilinmesi ve d\u00fczenli takip erken tan\u0131 a\u00e7\u0131s\u0131ndan \u00f6nemlidir. Erken tan\u0131 konulan hastalar\u0131n b\u00fcy\u00fck \u00e7o\u011funlu\u011funda ba\u015far\u0131 ile tedavi m\u00fcmk\u00fcnd\u00fcr.
Risk Fakt\u00f6rleri ve Nedenleri \u00a0<\/strong>
Kal\u0131nbarsak kanseri olu\u015fumunu tek bir nedene ba\u011flamak m\u00fcmk\u00fcn de\u011fildir. Olu\u015fumu i\u00e7in pek \u00e7ok fakt\u00f6r \u015fu\u00e7lanmaktad\u0131r. Baz\u0131 durumlarda kanser geli\u015fim riski artmaktad\u0131r. Olgular\u0131n %75’inde ya\u015f d\u0131\u015f\u0131nda hi\u00e7bir risk fakt\u00f6r\u00fc bulunmayabilir.
\u00b7\u0130leri ya\u015f:<\/strong>Kal\u0131n barsak kanser geli\u015fme s\u0131kl\u0131\u011f\u0131 ileri ya\u015flarda artmaktad\u0131r. Hastalar\u0131n b\u00fcy\u00fck \u00e7o\u011funlu\u011fu (%90-95’i) 50 ya\u015f\u0131n \u00fcst\u00fcndedir. G\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 40 ya\u015f\u0131n alt\u0131nda %0.05 iken, 60 ya\u015f \u00fcst\u00fcnde %3-4’e \u00e7\u0131kmaktad\u0131r.
\u00b7Polipler:\u00a0<\/strong>Kal\u0131n barsak i\u00e7ine do\u011fru \u00e7\u0131k\u0131nt\u0131 yapan iyi huylu olu\u015fumlard\u0131r. Bu poliplerin tamam\u0131 kansere d\u00f6n\u00fc\u015fmez, ancak, kal\u0131n ba\u011f\u0131rsak kanserlerinin b\u00fcy\u00fck \u00e7o\u011funlu\u011fu\u00a0poliplerden geli\u015fti\u011fi i\u00e7in, bunlar\u0131n kolonoskopi ile \u00e7\u0131kart\u0131larak incelenmeleri gerekir.
\u00b7Ki\u015fisel \u00f6zge\u00e7mi\u015f:\u00a0<\/strong>Daha \u00f6nceden ge\u00e7irilmi\u015f kal\u0131n barsak kanseri veya adenomat\u00f6z polip\/t\u00fcm\u00f6r bulunan olgularda kal\u0131n barsak kanseri geli\u015fme riski fazlad\u0131r. \u00a0\u00a0Yumurtal\u0131k, mesane ve rahim kanseri bulunan ki\u015filerde de kal\u0131n ba\u011f\u0131rsak kanseri geli\u015fme riski normal pop\u00fclasyondan fazlad\u0131r.
\u00b7Ailede kal\u0131n barsak kanseri \u00f6yk\u00fcs\u00fc:<\/strong>\u00a0Birinci derece akrabalar\u0131nda kal\u0131n ba\u011f\u0131rsak kanseri bulunanlarda, bu tip kanser geli\u015fim riski 1.7 kat artar., ikiden fazla ki\u015fide varsa oran 2.7’ye \u00e7\u0131kar.\u00a0 \u00d6zellikle gen\u00e7 ya\u015fta (45 ya\u015f alt\u0131) ve birden fazla ki\u015fide bulunmas\u0131 riski artt\u0131r\u0131r (5-6 kat). Baz\u0131 kal\u0131n ba\u011f\u0131rsak kanserlerinde (kal\u0131tsal kolorektal kanser sendromu) ailesel ge\u00e7i\u015f g\u00f6zlenir.
\u00b7Ailesel Adenamot\u00f6z Polipozis Sendromu ve Ailesel Nonpolipozis Kolorektal Kanser:<\/strong>\u00a0Bunlar kal\u0131tsal ge\u00e7erler. Ailesel adenomat\u00f6z polipozis sendromunda kal\u0131n ba\u011f\u0131rsa\u011f\u0131n i\u00e7inde y\u00fczlerce hatta binlerce polip bulunur. Bunlarda kansere d\u00f6n\u00fc\u015f\u00fcm g\u00f6zlendi\u011fi i\u00e7in belli bir ya\u015fa gelmeden t\u00fcm kal\u0131n barsa\u011f\u0131n \u00e7\u0131kar\u0131lmas\u0131 gerekir.
\u00b7Beslenme al\u0131\u015fkanl\u0131klar\u0131:\u00a0<\/strong>Y\u00fcksek ya\u011f ve protein (k\u0131rm\u0131z\u0131 et) i\u00e7eren y\u00fcksek kalorili diyet ve d\u00fc\u015f\u00fck lif i\u00e7eren (az posa b\u0131rakan b\u0131rakan) g\u0131dalarla beslenme riski artar\u0131rken, y\u00fcksek lifli, \u00e7ok posa b\u0131rakan g\u0131dalarla beslenme ve bol meyve ve sebze ile beslenme riski azalt\u0131r.
\u00b7Alkol<\/strong>
\u00b7Sigara<\/strong>
\u00b7\u0130nflematuar barsak hastal\u0131klar\u0131:\u00a0<\/strong>\u00dclseratif kolit ve Crohn hastal\u0131\u011f\u0131nda \u00a0kla\u0131n barsak kanseri geli\u015fim riski artar. \u00d6zellikle \u00fclseratif kolit varl\u0131\u011f\u0131nda risk \u00e7ok artt\u0131\u011f\u0131ndan bu olgular\u0131n d\u00fczenli takibi gerekir.
\u00b7\u00dcreterosigmoidostomi:\u00a0<\/strong>Kal\u0131n barsaktan mesane olu\u015fturulanlarda, idrarda bulunan baz\u0131 kanser yap\u0131c\u0131 etkenlerle kanser olu\u015fma riski artar.
\u00b7Radyasyon<\/strong>
\u00b7D\u00fc\u015f\u00fck fiziksel aktivite<\/strong>
\u00b7\u015ei\u015fmanl\u0131k<\/strong>
\u00b7Y\u00fcksek sosyoekonomik durum<\/strong>
\u00b7Genetik fakt\u00f6rler<\/strong>
\u00b7Irk:\u00a0<\/strong>Beyaz \u0131rkta rektum (kal\u0131n barsa\u011f\u0131n son k\u0131sm\u0131) kanser riski fazla iken, siyah \u0131rkta kal\u0131n barsa\u011f\u0131n di\u011fer \u00fcst k\u0131s\u0131mlar\u0131n\u0131n kanser riski daha fazlad\u0131r.
\u00b7B\u00f6lgesel farkl\u0131l\u0131k:<\/strong>Kuzey Amerika’da s\u0131k g\u00f6zlenirken, Afrika’da az g\u00f6zlenir.
Belirtileri:<\/strong>
Belirti ve bulgular kanserin kolonda bulundu\u011fu yere g\u00f6re de\u011fi\u015fir.Son k\u0131s\u0131mda bulunan kanserlerde kanama, kab\u0131zl\u0131k, d\u0131\u015fk\u0131lama zorluklar\u0131 ve t\u0131kanma belirtileri \u00f6n planda iken, sa\u011f tarafta bulunan t\u00fcm\u00f6rlerde, kolon burada daha geni\u015f oldu\u011fu i\u00e7in t\u0131kanma belirtileri daha ge\u00e7 g\u00f6zlenir. Kanama bariz de\u011fildir, yava\u015f ve gizli oldu\u011fu i\u00e7in kans\u0131zl\u0131\u011fa neden olur.
Bu hastalarda da, t\u00fcm kanserlerde g\u00f6zlenen baz\u0131 bulgular g\u00f6zlenir.
\u0130stemsiz kilo kayb\u0131
Halsizlik, yorgunluk hissi
Kans\u0131zl\u0131k
Mide barsak sistemine ait baz\u0131 \u015fikayetler g\u00f6zlenebilir:
Kar\u0131n a\u011fr\u0131s\u0131
Kar\u0131nda gaz, \u015fi\u015fkinlik
Kusma
A\u015fa\u011f\u0131da say\u0131lan belirtilerin varl\u0131\u011f\u0131nda ise, kal\u0131n ba\u011f\u0131rsak kanserinden \u015f\u00fcphelenmek gerekir.
D\u0131\u015fk\u0131lama al\u0131\u015fkanl\u0131\u011f\u0131nda g\u00f6zlenen ve devam eden de\u011fi\u015fiklikler
Kab\u0131zl\u0131k
\u0130shal
D\u0131\u015fk\u0131 i\u00e7inde kan bulunmas\u0131, katran renginde d\u0131\u015fk\u0131
D\u0131\u015fk\u0131 \u00e7ap\u0131n\u0131n incelmesi (kalem gibi d\u0131\u015fk\u0131)
D\u0131\u015fk\u0131lama sonunda tam bo\u015falamama hissi
T\u00fcm\u00f6r tan\u0131s\u0131nda gecikme sonucu, barsakta t\u0131kan\u0131kl\u0131k (gaz ve gayta \u00e7\u0131karamama, kar\u0131n a\u011fr\u0131s\u0131, bulant\u0131, kusma, kar\u0131n \u015fi\u015fli\u011fi, vd) ve perforasyon (t\u00fcm\u00f6r\u00fcn delinerek, gaytan\u0131n ve t\u00fcm\u00f6r\u00fcn kar\u0131n i\u00e7ine yay\u0131lmas\u0131na ba\u011fl\u0131 kar\u0131n i\u00e7inde iltihap gibi \u00f6l\u00fcmc\u00fcl komplikasyonlar (istenmeyen durumlar) geli\u015febilir. Kanser, ince barsaklara, mesaneye, kad\u0131n yollar\u0131na (rahim ve vajene), idar yollar\u0131na ve cilde a\u00e7\u0131labilir. T\u00fcm\u00f6r bu organlara yay\u0131ld\u0131\u011f\u0131 gibi, bu organlarda enfeksiyona da neden olur.
T\u00fcm\u00f6r bazen uzak organ (karaci\u011fer, akci\u011fer, beyin, kemik, vd) yay\u0131l\u0131m\u0131na ba\u011fl\u0131 bulgularla (kar\u0131n a\u011fr\u0131s\u0131, \u00f6ks\u00fcr\u00fck, ba\u015fa\u011fr\u0131s\u0131, kemik a\u011fr\u0131lar\u0131, vs ) ba\u015fvurabilir.
Tan\u0131:<\/strong>
Hastan\u0131n hikayesi, fizik muayene ve laboratuar ve g\u00f6r\u00fcnt\u00fcleme y\u00f6ntemleri ile tan\u0131 konulur.
Fizik muayene ve rektal tu\u015fe:<\/strong>\u0130yi bir fizik muayene \u015fartt\u0131r. Kar\u0131n muayenesinde kitle tespit edilebilir. Barsa\u011f\u0131n son k\u0131sm\u0131n\u0131n parmakla muayenesi \u015fartt\u0131r. Kal\u0131n ba\u011f\u0131rsak kanserleri en s\u0131k rektum denilen son k\u0131s\u0131mda g\u00f6zlenir. Parmakla yap\u0131lan rektal muayene ile son 7 cm.lik k\u0131sm\u0131 de\u011ferlendirmek m\u00fcmk\u00fcnd\u00fcr
Baryumlu Kolon Grafisi:\u00a0<\/strong>Anal yoldan kontrast madde (Baryum ) verilerek \u00e7ekilir. Hava verilerek, \u00e7ift kontrastl\u0131 film \u00e7ekmek daha ince detaylar\u0131n g\u00f6r\u00fclmesini sa\u011flar
Kolonoskopi:<\/strong>\u00a0B\u00fck\u00fclebilir ve \u0131\u015f\u0131kl\u0131 hortum \u015feklinde bir t\u00fcp kullanarak kolonun i\u00e7inin incelenmesidir. Bu i\u015flem s\u0131ras\u0131nda kitle veya yara g\u00f6r\u00fcld\u00fc\u011f\u00fcnde par\u00e7a al\u0131narak inceleme yap\u0131labildi\u011fi gibi, k\u00fc\u00e7\u00fck kitlelerin tama\u0131mn\u0131 \u00e7\u0131karmak ve kanamay\u0131 durdurmak m\u00fcmk\u00fcnd\u00fcr.
Virtual kolonoskopi:\u00a0<\/strong>\u00dc\u00e7 boyutlu \u00e7ekilen filmler ile kolonun i\u00e7i g\u00f6sterilebilir. Ancak, par\u00e7a alma \u015fans\u0131 yoktur.
Direkt kar\u0131n grafisi:<\/strong>T\u0131kay\u0131c\u0131 kal\u0131n ba\u011f\u0131rsak t\u00fcm\u00f6rlerinde t\u0131kan\u0131kl\u0131\u011f\u0131 belirlemek amac\u0131yla kullan\u0131l\u0131r
Ultrasonografi, Bilgisayarl\u0131 tomografi, manyetik rezonans g\u00f6r\u00fcnt\u00fcleme, PET\u00a0<\/strong>gibi g\u00f6r\u00fcnt\u00fcleme y\u00f6ntemleri ile t\u00fcm\u00f6r\u00fcn tan\u0131s\u0131 konulabilir ve yayg\u0131nl\u0131\u011f\u0131 de\u011ferlendirlebilir.
D\u0131\u015fk\u0131da DNA testi:\u00a0<\/strong>D\u0131\u015fk\u0131da anormal DNA tesbit edilmesi esas\u0131na dayan\u0131r. Test negatif \u00e7\u0131karsa 5 y\u0131lda tekrarlan\u0131r.
Laboratuar<\/strong>
Kan testleri:<\/strong>Kan say\u0131m\u0131, karaci\u011fer fonksiyon testleri, vd testler
T\u00fcm\u00f6r belirte\u00e7leri:<\/strong>CEA (karsino embriyojenik antijen) testi: kolorektal kanserli insanlar\u0131n kan\u0131nda normalden daha y\u00fcksek bulunur.\u00a0 Ayr\u0131ca n\u00fcksleri belirlemede de kullan\u0131l\u0131r.
Ay\u0131r\u0131c\u0131 tan\u0131:<\/strong>
Mide barsak sisteminin kanser d\u0131\u015f\u0131 hastal\u0131klar\u0131: \u00fclser, barsak iltihab\u0131, vd
Hemoroid hastal\u0131\u011f\u0131: Hemoroidli hastalarda kal\u0131n barsak kanseri bulunabilece\u011fi, bu nedenle kanama ve di\u011fer \u015fikayetlerin tamamen hemoroide ba\u011flanmay\u0131p, t\u00fcm barsa\u011f\u0131n incelenmesi gerekir.
Tedavi:<\/strong>
Kal\u0131n ba\u011f\u0131rsak kanserlerinin tedavisi, t\u00fcm\u00f6r\u00fcn evresine, yerle\u015fim yerine ve hastan\u0131n sa\u011fl\u0131k durumuna g\u00f6re de\u011fi\u015fir. Erken tan\u0131 ve tedavi k\u00fcr \u015fans\u0131n\u0131 artt\u0131r\u0131r.
Kal\u0131n ba\u011f\u0131rsak kanserinin tedavisinde ba\u015fl\u0131ca cerrahi tedavi (t\u00fcm\u00f6r\u00fcn \u00e7\u0131kar\u0131lmas\u0131), kemoterapi (kanser ila\u00e7lar\u0131 ile tedavi) ve radyoterapi (\u0131\u015f\u0131nla tedavi) kullan\u0131l\u0131r. Bunun d\u0131\u015f\u0131nda biyolojik y\u00f6ntemlerle tedavi yakla\u015f\u0131mlar\u0131 \u00fczerine \u00e7al\u0131\u015fmalar devam etmektedir.
Tedavi y\u00f6ntemleri genellikle kombine \u015fekilde kullan\u0131l\u0131r.
Cerrahi tedavi:<\/strong>
\u00c7\u0131kar\u0131labilir t\u00fcm evre kal\u0131n barsak kanserlerinde ba\u015fl\u0131ca tedavi y\u00f6ntemidir. Erken evre kanserlerde tek ba\u015f\u0131na k\u00fcr ( tamamen tedavi) sa\u011flayabilir. Cerrahi tedavide t\u00fcm\u00f6r\u00fcn bulundu\u011fu barsak b\u00f6l\u00fcm\u00fc, t\u00fcm\u00f6r\u00fcn muhtemel yay\u0131lma alanlar\u0131n\u0131 da i\u00e7erecek tarzda \u00e7\u0131kar\u0131l\u0131r. Kanser cerrahisi \u00f6zellik arz eden bir cerrahi \u015feklidir. Kanserin yay\u0131lmas\u0131 muhtemel lenf d\u00fc\u011f\u00fcmlerinin \u00e7\u0131kar\u0131lmas\u0131, hastan\u0131n tedavi sonras\u0131 ya\u015fam s\u00fcresini etkileyen fakt\u00f6rlerden birisidir. T\u00fcm\u00f6rl\u00fc barsak dokusu \u00e7\u0131kar\u0131ld\u0131ktan sonra u\u00e7lar birbirine dikilerek, barsak devaml\u0131l\u0131\u011f\u0131 sa\u011flan\u0131r. Baz\u0131 \u00f6zel durumlarda, ge\u00e7ici veya kal\u0131c\u0131 kolostomi (barsa\u011f\u0131n cilde a\u011f\u0131zla\u015ft\u0131r\u0131lmas\u0131) gerekebilir.
Kemoterapi (\u00a0<\/strong>kanser h\u00fccrelerini \u00f6ld\u00fcren ila\u00e7larla yap\u0131lan tedavi ) ve\u00a0radyoterapi<\/strong>\u00a0(d\u0131\u015fardan \u0131\u015f\u0131n verilerek kanser h\u00fccrelerinin \u00f6ld\u00fcr\u00fclmesi)\u00a0 genellikle cerrahi tedavi sonras\u0131 uygulanmakla birlikte, baz\u0131 hastalarda tedavi \u00f6ncesi de uygulanabilir.
Cerrahi tedavi ve radyoterapi kanserin b\u00f6lgesel tedavisini sa\u011flarken, kemoterapi y\u00f6ntemi ile, v\u00fccuda yay\u0131lm\u0131\u015f t\u00fcm kanser h\u00fccrelerini \u00f6ld\u00fcrmek m\u00fcmk\u00fcnd\u00fcr.
Biyolojik tedavi<\/strong>, v\u00fccudun savunma sistemini uyararak kanser h\u00fccrelerinin yok edilmesini ama\u00e7layan tedavi y\u00f6ntemidir.
Takip<\/strong>
T\u00fcm kanserlerde oldu\u011fu gibi , kal\u0131n ba\u011f\u0131rsak kanserlerinin de tedavi sonras\u0131 d\u00fczenli takibi \u015fartt\u0131r. Hastalar n\u00fcks (kanser ayn\u0131 veya kom\u015fu b\u00f6lgede tekrar ortaya \u00e7\u0131kmas\u0131) veya metastaz (v\u00fccudun ba\u015fka bir yerinde ortaya \u00e7\u0131kmas\u0131) a\u00e7\u0131s\u0131ndan takip edilir.
Hastalar kontrole \u00e7a\u011fr\u0131larak belli aralarla, fizik muayene, d\u0131\u015fk\u0131da gizli kan testi, kolonoskopi, akci\u011fer filmi, bilgisayarl\u0131 tomografi, PET, CEA ve di\u011fer baz\u0131 kan testleri yap\u0131l\u0131r. Ameliyattan\u00a0 sonra normal s\u0131n\u0131rlara d\u00fc\u015fen CEA de\u011feri, tekrar y\u00fckselmesi kanserin n\u00fcks\u00fcn\u00fc (tekrarlama) veya metastaz (uzak organ yay\u0131l\u0131m\u0131) varl\u0131\u011f\u0131n\u0131 g\u00f6sterir. Kanserli hastalarda, ba\u015fka organlarda da kanser g\u00f6r\u00fclebilece\u011fi i\u00e7in, kad\u0131nlarda meme, yumurtal\u0131k ve rahim a\u011fz\u0131 ve erkeklerde prostat muayeneleri yap\u0131lmal\u0131d\u0131r.
Tedavi sonras\u0131 ya\u015fama s\u00fcresi<\/strong>
Hastal\u0131\u011f\u0131n evresi ile orant\u0131l\u0131d\u0131r. Sadece barsak duvar\u0131na s\u0131n\u0131rl\u0131, barsa\u011f\u0131n kas tabakas\u0131n\u0131 a\u015fmam\u0131\u015f, lenf nodu ve uzak yay\u0131l\u0131m\u0131 olmayan t\u00fcm\u00f6rlerde tedavi sonras\u0131 5 y\u0131ll\u0131k ya\u015fam \u015fans\u0131 %80 civar\u0131nda iken, uzak organ yay\u0131l\u0131m\u0131 varl\u0131\u011f\u0131nda bu oran %5’in alt\u0131na d\u00fc\u015fer.
Korunma\u00a0
Beslenme \u015feklinin d\u00fczenlenmesi<\/strong>
Y\u00fcksek lifli g\u0131da
Meyve ve sebze t\u00fcketiminin artt\u0131r\u0131lmas\u0131
Kalsiyum, D vitamini, E vitamini Folik asit al\u0131m\u0131 ve postmenopozal \u00f6strojen kullan\u0131m\u0131n\u0131n koruyucu oldu\u011fu bildirilmi\u015f olmakla beraber, yan etkileri a\u00e7\u0131s\u0131ndan doktor \u00f6nerisi ile kullan\u0131lmal\u0131d\u0131r.
Alkol ve sigaradan ka\u00e7\u0131n\u0131lmas\u0131<\/strong>
D\u00fczenli egzersiz<\/strong>
Menapoz \u00f6ncesi obesiteyi \u00f6nleme<\/strong>
Kolon poliplerinin \u00e7\u0131kar\u0131lmas\u0131:\u00a0<\/strong>T\u00fcm prekanser\u00f6z (kanser \u00f6nc\u00fcs\u00fc polipler) saptand\u0131\u011f\u0131nda \u00e7\u0131kar\u0131lmal\u0131d\u0131r.
Nonsteroid antiinflematuar ila\u00e7 ve aspirin kullan\u0131m\u0131n\u0131n\u00a0<\/strong>kolorektal kanserden \u00f6l\u00fcm riskini azaltt\u0131\u011f\u0131n\u0131 g\u00f6stermi\u015f olmakla birlikte, mide kanamas\u0131 ve di\u011fer yan etkileri a\u00e7\u0131s\u0131ndan doktor kontrol\u00fcnde kullan\u0131lmas\u0131 gerekir.
Tarama program\u0131na kat\u0131lma<\/strong>
Tarama programlar\u0131<\/strong>
Riskli olmayan grupta 40 ya\u015f\u0131ndan sonra, riskli gruplarda daha erken ya\u015flarda ba\u015flayarak belli aralarla yap\u0131lan rektal muayene tan\u0131 a\u00e7\u0131s\u0131ndan \u00f6nemlidir. Hem son 7 cm.b\u00f6lgedeki kitleleri saptamak, hem de gaytada kan bulunup bulunmad\u0131\u011f\u0131n\u0131 saptamak kolon kanseri tan\u0131s\u0131 a\u00e7\u0131s\u0131ndan \u00f6nemlidir.
50 ya\u015f\u0131ndan sonra y\u0131lda bir defa gaitada gizli kan testi yap\u0131lmas\u0131 da kal\u0131n ba\u011f\u0131rsak kanseri tan\u0131s\u0131 a\u00e7\u0131s\u0131ndan \u00f6nemlidir. Pozitif olmas\u0131 gayta i\u00e7inde kan oldu\u011funu g\u00f6sterir, direkt kal\u0131n ba\u011f\u0131rsak kanseri tan\u0131s\u0131 koydurmamakla birlikte, ilave tan\u0131 i\u015flemlerinin yap\u0131lmas\u0131 a\u00e7\u0131s\u0131ndan uyar\u0131c\u0131 olur.
Riskli olmayan grupta 50 ya\u015f\u0131ndan itibaren her 5 y\u0131lda (3-10 y\u0131lda) bir defa sigmoidoskopi veya kolonoskopi yap\u0131lmas\u0131, daha \u015fikayete neden olmam\u0131\u015f kal\u0131n ba\u011f\u0131rsak kanserlerinin erken tan\u0131s\u0131 a\u00e7\u0131s\u0131ndan \u00f6nemlidir. Polip tespit edilenlerde, polipte bulunan riske g\u00f6re (displazi- yap\u0131s\u0131 de\u011fi\u015fmi\u015f h\u00fccre- varl\u0131\u011f\u0131nda) takip s\u0131kl\u0131\u011f\u0131 artt\u0131r\u0131labilir. \u0130lk kolonoskopisi normal olan ve riskli grupta olmayan olgularda 5-10 y\u0131ll\u0131k aralarla kolonoskopi yap\u0131lmas\u0131 yeterlidir.
Riskli gruplarda tarama ve tan\u0131 y\u00f6ntemlerine daha erken ba\u015flanmal\u0131 ve daha s\u0131k yap\u0131lmal\u0131d\u0131r. Aile hikayesinde 50 ya\u015f \u00f6ncesi kal\u0131n ba\u011f\u0131rsak \u00a0kanseri saptanm\u0131\u015f olgularda, g\u00f6r\u00fclme ya\u015f\u0131n\u0131n 10 ya\u015f evvelinden takiplere (kolonoskopi, vd) ba\u015flanmas\u0131 gerekir.\u00a0
Sonu\u00e7 olarak, kal\u0131n ba\u011f\u0131rsak kanseri tedavisi m\u00fcmk\u00fcn olan bir hastal\u0131kt\u0131r. Erken tan\u0131 tedavinin ba\u015fl\u0131ca anahtar\u0131d\u0131r. D\u0131\u015fk\u0131lama al\u0131\u015fkanl\u0131\u011f\u0131ndaki de\u011fi\u015fiklikler \u00f6nemsenmeli ve gecikmeden doktora ba\u015fvurulmal\u0131d\u0131r. Tarama programlar\u0131 erken tan\u0131y\u0131 ve k\u00fcr \u015fans\u0131n\u0131 artt\u0131ran en \u00f6nemli fakt\u00f6rd\u00fcr.<\/p>\n\n\n\n

<\/h2>\n","protected":false},"excerpt":{"rendered":"

Kal\u0131n ba\u011f\u0131rsaklar sindirim sistemimizin son k\u0131sm\u0131n\u0131 olu\u015fturur. Yakla\u015f\u0131k 150-200 cm boyunda olup, son 15 cm.lik k\u0131sm\u0131na rektum ad\u0131 verilir. Bu … Continue ReadingKal\u0131n Ba\u011f\u0131rsak Kanseri<\/span><\/a><\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[27,28,26],"class_list":["post-53","post","type-post","status-publish","format-standard","hentry","category-bagirsak-cerrahisi","tag-sanliurfa-bagirsak-kanseri","tag-sanliurfa-kanser-cerrahisi","tag-sanliurfa-kolon-kanseri"],"_links":{"self":[{"href":"http:\/\/profdraliuzunkoy.com\/index.php?rest_route=\/wp\/v2\/posts\/53","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/profdraliuzunkoy.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/profdraliuzunkoy.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/profdraliuzunkoy.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/profdraliuzunkoy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=53"}],"version-history":[{"count":1,"href":"http:\/\/profdraliuzunkoy.com\/index.php?rest_route=\/wp\/v2\/posts\/53\/revisions"}],"predecessor-version":[{"id":54,"href":"http:\/\/profdraliuzunkoy.com\/index.php?rest_route=\/wp\/v2\/posts\/53\/revisions\/54"}],"wp:attachment":[{"href":"http:\/\/profdraliuzunkoy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=53"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/profdraliuzunkoy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=53"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/profdraliuzunkoy.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=53"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}